BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Is BPC 157 Banned? Oral vs. Injectable Forms Explained Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #